Provide your contact details to the exhibitor. Optionally, you may also add a personal message.
Your name, phone number, and e-mail address are subject to the submission of personal data. Messe Düsseldorf GmbH expressly points out that for a data transmission into third countries, for which no adequacy decision of the EU-commission is on hand certifying an adequate level of protection of personal data, it is not ensured that there are appropriate safeguards for the protection of personal data on hand.
Please log in
You must be logged in to send the contact request.
An error has occurred
Please check your internet connection or try again later.
Message has been sent
Your message to the exhibitor was sent successfully.
EchoS is the very first radiation-free solution for bone health assessment at the axial sites through a very simple and fast echographic scan. EchoS is based on the proprietary R.E.M.S. Technology (Radiofrequency Echographic Multi Spectrometry), an innovative radiation-free method for bone density and quality assessment at the lumbar vertebrae and the femoral neck.
A new concept of bone health Paving a new way for bone health management through prevention, early diagnosis of osteoporosis and lifetime monitoring at the point of care.
- RADIATION FREE - AXIAL SITES - ACCURATE - BONE DENSITY - BONE FRAGILITY - BODY COMPOSITION - PORTABLE - FDA APPROVED
The new State-of-the-Art in bone densitometry thanks to the extreme ease and the high performance setting a new standard in bone health assessment.
Echolight is a growing med-tech company located in Italy pioneering the very first radiation-free solution for bone health assessment at the axial sites.
In less than three years it has built a sales network of 40 distributors and several hundreds of satisfied customers all over the world.
We secured all the standard certifications: UNI CEI EN ISO 13485: 2016, UNI EN ISO 9001: 2015 Quality Management System, CE Mark, FDA Clearence and other main certifications all over the world for our innovative solutions.
In collaboration with the National Council of Research of Italy, we carried out international multi-center studies for the clinical validation of the proprietary technology in the most important reference centers for the diagnosis of osteoporosis under the lead of our prestigious scientific advisory board.
The next generation of healthcare
We want to be in the forefront of innovation in the healthcare industry, introducing new advanced solutions to give people a better life.